Skip to content
10-K

Annual Report

Kronos Bio, Inc.

0001741830-25-000009

← back to feed
Filed
Mar 18, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2024 60.07M sh
Shares Diluted FY 2024 · Dec 31, 2023 57.74M sh
Capex FY 2024 · Dec 31, 2024 $4K
Capex FY 2024 · Dec 31, 2023 $679K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$65.44M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$78.58M
Short Term Investments FY 2024 · Dec 31, 2024 $27.85M
Short Term Investments FY 2024 · Dec 31, 2023 $108.67M
Cash And Equivalents FY 2024 · Dec 31, 2024 $84.57M
Cash And Equivalents FY 2024 · Dec 31, 2023 $64.33M
Stockholders Equity FY 2024 · Dec 31, 2024 $87.58M
Stockholders Equity FY 2024 · Dec 31, 2023 $159.08M
Stockholders Equity FY 2024 · Dec 31, 2022 $244.5M
Current Liabilities FY 2024 · Dec 31, 2024 $15.28M
Current Liabilities FY 2024 · Dec 31, 2023 $24.7M
Total Liabilities FY 2024 · Dec 31, 2024 $36.78M
Total Liabilities FY 2024 · Dec 31, 2023 $54.2M
Current Assets FY 2024 · Dec 31, 2024 $115.23M
Current Assets FY 2024 · Dec 31, 2023 $178.78M
Total Assets FY 2024 · Dec 31, 2024 $124.36M
Total Assets FY 2024 · Dec 31, 2023 $213.28M
Eps Diluted FY 2024 · Dec 31, 2024 −$1.43
Eps Diluted FY 2024 · Dec 31, 2023 −$1.95
Eps Basic FY 2024 · Dec 31, 2024 −$1.43
Eps Basic FY 2024 · Dec 31, 2023 −$1.95
Sga Expense FY 2024 · Dec 31, 2024 $24.62M
Sga Expense restated FY 2024 · Dec 31, 2023 $38.97M
Rd Expense FY 2024 · Dec 31, 2024 $48.66M
Rd Expense restated FY 2024 · Dec 31, 2023 $84.52M
Net Income FY 2024 · Dec 31, 2024 −$86.08M
Net Income FY 2024 · Dec 31, 2023 −$112.67M
Operating Income FY 2024 · Dec 31, 2024 −$92.89M
Operating Income restated FY 2024 · Dec 31, 2023 −$122.08M
Revenue FY 2024 · Dec 31, 2024 $9.85M
Revenue FY 2024 · Dec 31, 2023 $6.29M